Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma.

Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, Brem S, O'Rourke DM, Morrissette JJD.

Acad Pathol. 2019 May 27;6:2374289519848353. doi: 10.1177/2374289519848353. eCollection 2019 Jan-Dec.

2.

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia.

McMahon CM, Canaani J, Rea B, Sargent RL, Qualtieri JN, Watt CD, Morrissette JJD, Carroll M, Perl AE.

Blood Adv. 2019 May 28;3(10):1581-1585. doi: 10.1182/bloodadvances.2018029496. No abstract available.

3.

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.

McMahon CM, Ferng T, Canaani J, Wang ES, Morrissette JJD, Eastburn DJ, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater EA, DeFilippis R, Peretz CAC, McGary LHF, Deihimi S, Logan AC, Luger SM, Shah NP, Carroll M, Smith CC, Perl AE.

Cancer Discov. 2019 Aug;9(8):1050-1063. doi: 10.1158/2159-8290.CD-18-1453. Epub 2019 May 14.

PMID:
31088841
4.

Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.

Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, Andruss BF.

J Mol Diagn. 2019 Jul;21(4):718-733. doi: 10.1016/j.jmoldx.2019.03.002. Epub 2019 Apr 23.

5.

Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.

Hatem J, Schrank-Hacker AM, Watt CD, Morrissette JJ, Rubin AI, Kim EJ, Nasta SD, Wasik MA, Bogusz AM.

Diagn Pathol. 2016 Dec 19;11(1):137.

6.

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing.

Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ.

PLoS One. 2016 Apr 4;11(4):e0152851. doi: 10.1371/journal.pone.0152851. eCollection 2016.

7.

Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone.

Nybakken GE, Canaani J, Roy D, Morrissette JD, Watt CD, Shah NP, Smith CC, Bagg A, Carroll M, Perl AE.

Leukemia. 2016 Jun;30(6):1422-5. doi: 10.1038/leu.2015.320. Epub 2015 Nov 20. No abstract available.

8.

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE.

Haematologica. 2015 Oct;100(10):e412-4. doi: 10.3324/haematol.2015.129346. Epub 2015 Jun 25. No abstract available.

9.

Ectopic hypercellular parathyroid tissue of the mediastinum masquerading as metastatic adenocarcinoma on positron emission tomography-computed tomography scan.

Aggarwal C, Shi WY, Watt CD, van Deerlin VM, Haas AR, Simone CB 2nd, Yu GH.

J Clin Oncol. 2014 Oct 20;32(30):e101-3. doi: 10.1200/JCO.2013.49.7628. Epub 2014 Feb 18. No abstract available.

PMID:
24550426
10.

Multifocal fibrosing thyroiditis and its association with papillary thyroid carcinoma using BRAF pyrosequencing.

Frank R, Baloch ZW, Gentile C, Watt CD, LiVolsi VA.

Endocr Pathol. 2014 Sep;25(3):236-40. doi: 10.1007/s12022-013-9289-0.

PMID:
24337906
11.

Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies.

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans T, Langer C.

Clin Lung Cancer. 2013 Sep;14(5):581-91. doi: 10.1016/j.cllc.2013.05.002. Epub 2013 Jul 1.

12.

Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans T, Langer C.

Lung Cancer. 2013 Sep;81(3):347-353. doi: 10.1016/j.lungcan.2013.05.011. Epub 2013 Jun 24.

13.

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.

Aisner DL, Deshpande C, Baloch Z, Watt CD, Litzky LA, Malhotra B, Sepulveda AR, Langer C, Evans T, Van Deerlin VM.

Diagn Cytopathol. 2013 Apr;41(4):316-23. doi: 10.1002/dc.21851. Epub 2011 Nov 18.

15.

Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR-ABL1 on the international reporting scale.

Brown JT, Laosinchai-Wolf W, Hedges JB, Watt CD, Van Deerlin VM, Fletcher L, Branford S, Labourier E.

Blood Cancer J. 2011 Mar;1(3):e13. doi: 10.1038/bcj.2011.10. Epub 2011 Mar 25.

16.

Molecular diagnosis of acute myeloid leukemia.

Watt CD, Bagg A.

Expert Rev Mol Diagn. 2010 Nov;10(8):993-1012. doi: 10.1586/erm.10.85. Review.

PMID:
21080817
17.

Cloning and characterization of a novel MyoD enhancer-binding factor.

Yamamoto M, Watt CD, Schmidt RJ, Kuscuoglu U, Miesfeld RL, Goldhamer DJ.

Mech Dev. 2007 Sep-Oct;124(9-10):715-28. Epub 2007 Jul 10.

19.
20.

MD-PhD students in a major training program show strong interest in becoming surgeon-scientists.

Ahn J, Watt CD, Greeley SA, Bernstein J.

Clin Orthop Relat Res. 2004 Aug;(425):258-63.

PMID:
15292817

Supplemental Content

Support Center